Montse Visa

Dr. Montse Visa

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LCLisa Cadavez
Lisa Cadavez
JMJoel Montane
Joel Montane
GAGema Alcarraz-Vizán
Gema Alcarraz-Vizán
MVMontse Visa
Montse Visa
LVLaia Vidal-Fàbrega
Laia Vidal-Fàbrega
ANAnna Novials
Anna Novials
In type 2 diabetes, beta-cell dysfunction is thought to be due to several causes, one being the formation of toxic protein aggregates called islet amyloid, formed by accumulations of misfolded human islet amyloid polypeptide (hIAPP). The process of hIAPP misfolding and aggregation is one of the factors that may activate the unfolded protein response (UPR), perturbing endoplasmic reticulum (ER) homeostasis. Molecular chaperones have been described to be important in regulating ER response to ER stress. In the present work, we evaluate the role of chaperones in a stressed cellular model of hIAPP overexpression. A rat pancreatic beta-cell line expressing hIAPP exposed to thapsigargin or treated with high glucose and palmitic acid, both of which are known ER stress inducers, showed an increase in ER stress genes when compared to INS1E cells expressing rat IAPP or INS1E control cells. Treatment with molecular chaperone glucose-regulated protein 78 kDa (GRP78, also known as BiP) or protein disulfite isomerase (PDI), and chemical chaperones taurine-conjugated ursodeoxycholic acid (TUDCA) or 4-phenylbutyrate (PBA), alleviated ER stress and increased insulin secretion in hIAPP-expressing cells. Our results suggest that the overexpression of hIAPP induces a stronger response of ER stress markers. Moreover, endogenous and chemical chaperones are able to ameliorate induced ER stress and increase insulin secretion, suggesting that improving chaperone capacity can play an important role in improving beta-cell function in type 2 diabetes.

1 November 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MSMaud Soty
Maud Soty
MVMontse Visa
Montse Visa
SSSergi Soriano
Sergi Soriano
MCMaría del Carmen Carmona
María del Carmen Carmona
ANAngel Nadal
Angel Nadal
ANAnna Novials
Anna Novials
Islet amyloid polypeptide (IAPP) is a major component of amyloid deposition in pancreatic islets of patients with type 2 diabetes. It is known that IAPP can inhibit glucose-stimulated insulin secretion; however, the mechanisms of action have not yet been established. In the present work, using a rat pancreatic beta-cell line, INS1E, we have created an in vitro model that stably expressed human IAPP gene (hIAPP cells). These cells showed intracellular oligomers and a strong alteration of glucose-stimulated insulin and IAPP secretion. Taking advantage of this model, we investigated the mechanism by which IAPP altered beta-cell secretory response and contributed to the development of type 2 diabetes. We have measured the intracellular Ca(2+) mobilization in response to different secretagogues as well as mitochondrial metabolism. The study of calcium signals in hIAPP cells demonstrated an absence of response to glucose and also to tolbutamide, indicating a defect in ATP-sensitive potassium (K(ATP)) channels. Interestingly, hIAPP showed a greater maximal respiratory capacity than control cells. These data were confirmed by an increased mitochondrial membrane potential in hIAPP cells under glucose stimulation, leading to an elevated reactive oxygen species level as compared with control cells. We concluded that the hIAPP overexpression inhibits insulin and IAPP secretion in response to glucose affecting the activity of K(ATP) channels and that the increased mitochondrial metabolism is a compensatory response to counteract the secretory defect of beta-cells.

25 March 2015 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MVMontse Visa
Montse Visa
GAGema Alcarraz‐Vizán
Gema Alcarraz‐Vizán
JMJoel Montane
Joel Montane
LCLisa Cadavez
Lisa Cadavez
CCCarlos Castaño
Carlos Castaño
ANAnna Novials
Anna Novials
The toxic effects of human islet amyloid polypeptide (IAPP) on pancreatic islets have been widely studied. However, much less attention has been paid to the physiologic actions of IAPP on pancreatic β cells, which secrete this peptide together with insulin upon glucose stimulation. Here, we aimed to explore the signaling pathways and mitogenic actions of IAPP on β cells. We show that IAPP activated Erk1/2 and v‐akt murine thymoma viral oncogene homolog 1 (Akt) at the picomolar range (10‐100 pM) in mouse pancreatic islets and MIN6 β cells cultured at low glucose concentrations. In contrast, IAPP decreased the induction of these pathways by high glucose levels. Consistently, IAPP induced a 1.7‐fold increase of β‐cell proliferation at low‐glucose conditions, whereas it reduced β‐cell proliferation at high glucose levels. Strikingly, the specific antagonist of the IAPP receptor AC187 (100 nM) decreased the activation of Erk1/2 and Akt and reduced β‐cell proliferation by 24% in glucose‐stimulated β cells, uncovering a key role of endogenously released IAPP in β‐cell responses to glucose. We conclude that exogenously added IAPP exerts a dual effect on β‐cell mitogenic signaling and proliferation, depending on the glucose concentration. Importantly, secreted IAPP contributes to the signaling and mitogenic response of β cells to glucose through an autocrine mechanism.— Visa, M., Alcarraz‐Vizán, G., Montane, J., Cadavez, L., Castaño, C., Villanueva‐Peñacarrillo, M. L., Servitja, J.‐M., Novials, A. Islet amyloid polypeptide exerts a novel autocrine action in β‐cell signaling and proliferation. FASEB J . 29, 2970‐2979 (2015). www.fasebj.org

28 November 2019 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
SJStefan Jacob
Stefan Jacob
MKMartin Köhler
Martin Köhler
PTPhilip Tröster
Philip Tröster
MVMontse Visa
Montse Visa
CGConcha F. García‐Prieto
Concha F. García‐Prieto
PBPer-Olof Berggren
Per-Olof Berggren
The dynamics of cytoplasmic free Ca 2+ concentration ([Ca 2+ ] i ) in pancreatic β cells is central to our understanding of β‐cell physiology and pathology. In this context, there are numerous in vitro studies available but existing in vivo data are scarce. We now critically evaluate the anterior chamber of the eye as an in vivo, non‐invasive, imaging site for measuring [Ca 2+ ] i dynamics longitudinally in three dimensions and at single‐cell resolution. By applying a fluorescently labeled glucose analogue 2‐( N ‐(7‐Nitrobenz‐2‐oxa‐1,3‐diazol‐4‐yl)Amino)‐2‐Deoxyglucose in vivo, we followed how glucose almost simultaneously distributes to all cells within the islet volume, resulting in [Ca 2+ ] i changes. We found that almost all β cells in healthy mice responded to a glucose challenge, while in hyperinsulinemic, hyperglycemic mice about 80% of the β cells could not be further stimulated from fasting basal conditions. This finding indicates that our imaging modality can resolve functional heterogeneity within the β‐cell population in terms of glucose responsiveness. Importantly, we demonstrate that glucose homeostasis is markedly affected using isoflurane compared to hypnorm/midazolam anesthetics, which has major implications for [Ca 2+ ] i measurements. In summary, this setup offers a powerful tool to further investigate in vivo pancreatic β‐cell [Ca 2+ ] i response patterns at single‐cell resolution in health and disease.

23 October 2014 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
GAGema Alcarraz‐Vizán
Gema Alcarraz‐Vizán
PCPaola Casini
Paola Casini
LCLisa Cadavez
Lisa Cadavez
MVMontse Visa
Montse Visa
JMJoel Montane
Joel Montane
ANAnna Novials
Anna Novials
BACE2 (β‐site APP‐cleaving enzyme 2) is a protease localized in the brain, where it appears to play a role in the development of Alzheimer disease (AD). It is also found in the pancreas, although its biologic function is not fully known. Amyloidogenic diseases, including AD and type 2 diabetes mellitus (T2D), share the accumulation of abnormally folded and insoluble proteins that interfere with cell function. Islet amyloid polypeptide (IAPP) deposits are a key pathogenic feature of T2D. Within this context, we found by global gene expression profiling that BACE2 was up‐regulated in the rat pancreatic β‐cell line INS1E stably transfected with human IAPP gene (hIAPP‐INS1E). Glucose‐stimulated insulin secretion (GSIS) in hIAPP‐INS1E cells was 30% lower than in INS1E cells. Additionally, INS1E cells transfected with a transient overexpression of BACE2 showed a 60% decrease in proliferation, a 3‐fold increase in reactive oxygen species production, and a 25% reduction in GSIS compared to control cells. Remarkably, silencing of endogenous BACE2 in hIAPP‐INS1E cells resulted in a significant improvement in GSIS (3‐fold increase vs. untransfected cells), revealing the significant role of BACE2 expression in β‐cell function. Thus, BACE2 inhibition may be useful to recover insulin secretion in hIAPP‐INS1E defective cells and may be proposed as a therapeutic target for T2D.‐ Montane, J., Servitja, J.‐M., Novials, A. Inhibition of BACE2 counteracts hIAPP‐induced insulin secretory defects in pancreatic β‐cells. FASEB J. 29, 95–104 (2015). www.fasebj.org

15 August 2017 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
JMJoel Montane
Joel Montane
SPSara de Pablo
Sara de Pablo
CCCarlos Castaño
Carlos Castaño
JRJúlia Rodríguez-Comas
Júlia Rodríguez-Comas
LCLisa Cadavez
Lisa Cadavez
ANAnna Novials
Anna Novials
Human islet amyloid polypeptide (hIAPP) aggregation is associated with β‐cell dysfunction and death in type 2 diabetes (T2D). we aimed to determine whether in vivo treatment with chemical chaperone 4‐phenylbutyrate (PBA) ameliorates hIAPP‐induced β‐cell dysfunction and islet amyloid formation. Oral administration of PBA in hIAPP transgenic (hIAPP Tg) mice expressing hIAPP in pancreatic β cells counteracted impaired glucose homeostasis and restored glucose‐stimulated insulin secretion. Moreover, PBA treatment almost completely prevented the transcriptomic alterations observed in hIAPP Tg islets, including the induction of genes related to inflammation. PBA also increased β‐cell viability and improved insulin secretion in hIAPP Tg islets cultured under glucolipotoxic conditions. Strikingly, PBA not only prevented but even reversed islet amyloid deposition, pointing to a direct effect of PBA on hIAPP. This was supported by in silico calculations uncovering potential binding sites of PBA to monomeric, dimeric, and pentameric fibrillar structures, and by in vitro assays showing inhibition of hIAPP fibril formation by PBA. Collectively, these results uncover a novel beneficial effect of PBA on glucose homeostasis by restoring β‐cell function and preventing amyloid formation in mice expressing hIAPP in β cells, highlighting the therapeutic potential of PBA for the treatment of T2D.—Montane, J., de Pablo, S., Castaño, C., Rodríguez‐Comas, J., Cadavez, L., Obach, M., Visa, M., Alcarraz‐Vizán, G., Sanchez‐Martinez, M., Nonell‐Canals, A., Parrizas, M., Ser‐vitja, J.‐M., Novials, A. Amyloid‐induced β‐cell dysfunction and islet inflammation are ameliorated by 4‐phenylbutyrate (PBA) treatment. FASEB J. 31, 5296–5306 (2017). www.fasebj.org